Neuronal dysfunction and death are prominent features of the pathogenesis of AD related to changes of unknown origin in the APP metabolism, which leads to excessive levels of the long form of the amyloid peptide Aβ1–42 compared with the short Aβ1–40 form. Here, APP is linked to Alzheimer disease.